Imperial College London

DrYoumingZhang

Faculty of MedicineNational Heart & Lung Institute

Lecturer (non-clinical) in Respiratory Genomics
 
 
 
//

Contact

 

+44 (0)20 7594 7974y.zhang

 
 
//

Location

 

413Guy Scadding BuildingRoyal Brompton Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Zhang:2016:10.5528/wjtm.v5.i1.14,
author = {Zhang, Y},
doi = {10.5528/wjtm.v5.i1.14},
journal = {World Journal of Translational Medicine},
pages = {14--25},
title = {Potential therapeutic targets from genetic and epigenetic approaches for asthma},
url = {http://dx.doi.org/10.5528/wjtm.v5.i1.14},
volume = {5},
year = {2016}
}

RIS format (EndNote, RefMan)

TY  - JOUR
AB - Asthma is a complex disorder characterised by inflammation of airway and symptoms of wheeze and shortness of breath. Allergic asthma, atopic dermatitis and allergic rhinitis are immunoglobulin E (IgE) related diseases. Current therapies targeting asthma rely on non-specific medication to control airway inflammation and prevent symptoms. Severe asthma remains difficult to treat. Genetic and genomic approaches of asthma and IgE identified many novel loci underling the disease pathophysiology. Recent epigenetic approaches also revealed the insights of DNA methylation and chromatin modification on histones in asthma and IgE. More than 30 miRNAs have been identified to have regulation roles in asthma. Understanding the pathways of the novel genetic loci and epigenetic elements in asthma and IgE will provide new therapeutic means for clinical management of the disease in future.
AU - Zhang,Y
DO - 10.5528/wjtm.v5.i1.14
EP - 25
PY - 2016///
SN - 2220-6132
SP - 14
TI - Potential therapeutic targets from genetic and epigenetic approaches for asthma
T2 - World Journal of Translational Medicine
UR - http://dx.doi.org/10.5528/wjtm.v5.i1.14
UR - https://www.imperial.ac.uk/people/y.zhang
UR - https://www.wjgnet.com/2220-6132/abstract/v5/i1/14.htm
UR - http://hdl.handle.net/10044/1/28848
VL - 5
ER -